Take off with Anheuser-Busch InBev SA/NV (BUD): Get ready for trading

Anheuser-Busch InBev SA/NV (NYSE: BUD) stock fell -2.13% on Friday to $48.14 against a previous-day closing price of $49.19. With 1.06 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.32 million shares. During the session, the Beverages – Brewers company that operates in wider Consumer Defensive sector, reached to the highest price of $49.09 whereas the lowest price it dropped to was $48.13. The 52-week range on BUD shows that it touched its highest point at $67.91 and its lowest point at $47.23 during that stretch. It currently has a 1-year price target of $62.21. With its current market cap of 83.13 billion, BUD has annualized dividend of $1.13 while the current yield stands at 2.35%. Beta for the stock currently stands at 1.25.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BUD was down-trending over the past week, with a drop of -2.07%, but this was down by -6.01% over a month. Three-month performance dropped to -7.69% while six-month performance fell -20.11%. The stock lost -16.64% in the past year, while it has lost -20.50% so far this year. A look at the trailing 12-month EPS for BUD yields 1.87 with Next year EPS estimates of 3.44. For the next quarter, that number is 0.90. This implies an EPS growth rate of 801.90% for this year and 11.56% for next year. EPS is expected to grow by 11.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 27.40%.

Float and Shares Shorts:

At present, 2.01 billion BUD shares are outstanding with a float of 607.63 million shares on hand for trading. On Jul 14, 2022, short shares totaled 1.78 million, which was 0.10% higher than short shares on Jun 14, 2022. In addition to Mr. Michel Dimitrios Doukeris as the firm’s Chief Exec. Officer, Mr. Fernando Mommensohn Tennenbaum serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 5.79% of BUD’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 3.85% of BUD, in contrast to 2.11% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in BUD with 1.37% of the stake, Dodge & Cox holds 23,838,936 shares worth 23,838,936. A second-largest stockholder of BUD, Manulife Investment Management, holds 10,359,504 shares, controlling over 0.60% of the firm’s shares. Fisher Asset Management LLC is the third largest shareholder in BUD, holding 9,024,648 shares or 0.52% stake. With a 0.96% stake in BUD, the Dodge & Cox Stock Fund is the largest stakeholder. A total of 16,608,500 shares are owned by the mutual fund manager. The American Balanced Fund, which owns about 0.28% of BUD stock, is the second-largest Mutual Fund holder. It holds 4,899,061 shares valued at 236.92 million. John Hancock Fundamental Large Ca holds 0.24% of the stake in BUD, owning 4,125,575 shares worth 199.51 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BUD since 31 analysts follow the stock currently. There are 19 analysts who recommend BUY ratings, while 2 suggest SELL ratings. Of the remaining analysts, 8 believe that the stock is worth HOLDING, 2 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With BUD analysts setting a high price target of $80.00 and a low target of $52.50, the average target price over the next 12 months is $62.93. Based on these targets, BUD could surge 66.18% to reach the target high and rise by 9.06% to reach the target low. Reaching the average price target will result in a growth of 30.72% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. BUD will report FY 2022 earnings on 03/02/2023. Analysts have provided yearly estimates in a range of $3.56 being high and $2.52 being low. For BUD, this leads to a yearly average estimate of $3.04. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Anheuser-Busch InBev SA/NV surprised analysts by $0.01 when it reported $0.73 EPS against a consensus estimate of $0.72. The surprise factor in the prior quarter was $0.06. Based on analyst estimates, the high estimate for the next quarter is $0.96 and the low estimate is $0.80. The average estimate for the next quarter is thus $0.86.

Leave a Comment

Your email address will not be published. Required fields are marked *




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam